Planned Parenthood/Orange and San Bernardino Counties, INC.
Planned Parenthood/Orange and San Bernardino Counties, INC. was paid $229.11M by Medicaid between Jan 2018 and Dec 2024, across 104 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 13% of everything it billed.
ORANGE, CA 92866
Next to other Ambulatory Family Planning Facility providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 722,101 | $41.17M | |
| 2019 | 472,981 | $25.09M | |
| 2020 | 470,952 | $21.68M | |
| 2021 | 707,842 | $35.09M | |
| 2022 | 622,935 | $30.86M | |
| 2023 | 829,072 | $39.53M | |
| 2024incomplete | 781,444 | $35.68M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 218,697 | 206,826 | $28.82M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 9.9% | 26,001 | 25,885 | $22.72M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.7% | 231,814 | 215,767 | $19.97M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.8% | 593,191 | 536,134 | $17.88M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.4% | 582,904 | 528,147 | $16.85M |
| S4993 | Contraceptive pills for birth control | 6.0% | 101,124 | 100,680 | $13.77M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.8% | 48,115 | 46,408 | $10.91M |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 4.4% | 20,720 | 20,608 | $9.97M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.7% | 33,782 | 33,610 | $8.50M |
| J3490 | Unclassified drugs | 3.5% | 216,627 | 187,018 | $8.09M |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 3.2% | 9,454 | 9,407 | $7.26M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.8% | 98,273 | 93,652 | $6.50M |
92 more codes
| 11981 | 2.7% | 29,303 | $6.12M | |
| J7304 | Contraceptive supply, hormone containing patch, each | 2.4% | 4,987 | $5.51M |
| 87806 | 2.2% | 217,019 | $5.15M | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.2% | 39,828 | $5.14M |
| J7300 | Intrauterine copper contraceptive (paragard) | 2.2% | 7,230 | $5.09M |
| 58300 | 1.7% | 43,059 | $3.98M | |
| A4267 | Contraceptive supply, condom, male, each | 1.7% | 434,195 | $3.83M |
| 90651 | 1.5% | 13,278 | $3.34M | |
| 11976 | 1.3% | 55,667 | $2.98M | |
| 81025 | <1% | 586,932 | $1.94M | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 24,033 | $1.81M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 32,124 | $1.39M |
| 59840 | <1% | 8,690 | $1.39M | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 19,836 | $1.07M |
| 58301 | <1% | 31,402 | $882K | |
| 57454 | <1% | 13,495 | $777K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 3,858 | $641K |
| 99000 | <1% | 172,524 | $626K | |
| S5000 | Prescription drug, generic | <1% | 132,155 | $614K |
| Q3014 | Telehealth originating site facility fee | <1% | 28,243 | $549K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 33,852 | $497K |
| 83986 | <1% | 151,403 | $419K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 32,457 | $413K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 113,397 | $399K |
| 99201 | <1% | 3,790 | $351K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 4,443 | $319K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,891 | $295K |
| 90674 | <1% | 8,370 | $250K | |
| 59841 | <1% | 1,015 | $238K | |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | <1% | 1,332 | $197K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,448 | $156K |
| 99243 | <1% | 2,411 | $143K | |
| 55250 | <1% | 888 | $132K | |
| 99401 | <1% | 6,843 | $129K | |
| 81002 | <1% | 43,528 | $91K | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 19,294 | $89K |
| 96156 | <1% | 1,207 | $86K | |
| 99385 | <1% | 397 | $75K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14,211 | $67K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 805 | $62K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15,283 | $60K |
| Z1034 | <1% | 1,061 | $58K | |
| 0011A | <1% | 1,423 | $54K | |
| 0012A | <1% | 1,039 | $40K | |
| 85018 | <1% | 12,037 | $35K | |
| 90746 | <1% | 550 | $34K | |
| S5001 | Prescription drug, brand name | <1% | 14,650 | $29K |
| 57460 | <1% | 260 | $27K | |
| 90715 | <1% | 592 | $25K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 2,082 | $23K |
| 99402 | <1% | 598 | $19K | |
| 0064A | <1% | 543 | $18K | |
| 56501 | <1% | 391 | $18K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 2,166 | $18K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 289 | $17K |
| 76830 | Ultrasound, transvaginal | <1% | 249 | $17K |
| 86901 | <1% | 5,024 | $15K | |
| 87210 | <1% | 3,334 | $15K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 254 | $12K |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 770 | $12K |
| 59425 | <1% | 207 | $11K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 283 | $11K |
| 99442 | <1% | 2,373 | $10K | |
| 54056 | <1% | 247 | $9K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,382 | $9K |
| 99441 | <1% | 2,095 | $8K | |
| S0197 | Prenatal vitamins, 30-day supply | <1% | 2,438 | $4K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 403 | $4K |
| 90707 | <1% | 42 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 833 | $3K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 366 | $3K |
| 76857 | <1% | 55 | $2K | |
| 0001A | <1% | 52 | $2K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 34 | $2K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 76 | $1K |
| 86580 | <1% | 73 | $807.28 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 374 | $733.70 |
| 96127 | <1% | 173 | $544.30 | |
| 99242 | <1% | 12 | $470.12 | |
| 76882 | <1% | 13 | $294.63 | |
| 3074F | 0% | 1,310 | $0.00 | |
| 2000F | 0% | 342 | $0.00 | |
| 1036F | 0% | 766 | $0.00 | |
| H0001 | Alcohol and/or drug assessment | 0% | 91 | $0.00 |
| 99443 | 0% | 42 | $0.00 | |
| 3008F | 0% | 53 | $0.00 | |
| 3079F | 0% | 12 | $0.00 | |
| 3078F | 0% | 1,215 | $0.00 | |
| 1160F | 0% | 1,074 | $0.00 | |
| 1159F | 0% | 1,075 | $0.00 | |
| 88147 | 0% | 627 | $0.00 | |
| 1158F | 0% | 52 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Planned Parenthood/Orange and San Bernardino Counties, INC. | Anaheim, CA | $4.01M |
| Planned Parenthood/Orange and San Bernardino Counties, INC. | Mission Viejo, CA | $364K |
| Planned Parenthood/Orange and San Bernardino Counties, INC. | Westminster, CA | $302K |
| Planned Parenthood/Orange and San Bernardino Counties, INC. | Costa Mesa, CA | $227K |
| Planned Parenthood/Orange and San Bernardino Counties, INC. | Anaheim, CA | $200K |
| Planned Parenthood/Orange and San Bernardino Counties INC. | San Bernardino, CA | $168K |
| Planned Parenthood/Orange and San Bernardino Counties, INC. | Upland, CA | $168K |
| Planned Parenthood/Orange and San Bernardino Counties, INC. | Santa Ana, CA | $119K |
| Planned Parenthood/Orange and San Bernardino Counties, INC. | Victorville, CA | $95K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.